Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
27 hedge funds and large institutions have $27.3M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 7 closing their positions.
13% less funds holding
Funds holding: 31 → 27 (-4)
30% less capital invested
Capital invested by funds: $38.7M → $27.3M (-$11.5M)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$528K |
| 2 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$201K |
| 3 |
Renaissance Technologies
New York
|
+$121K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$47.1K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$29.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIS
AlphaOne Investment Services
West Chester,
Pennsylvania
|
-$948K |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$340K |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$289K |
| 4 |
DMK
David M. Knott
|
-$107K |
| 5 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$77K |
CORV Hedge Fund Activity: Q4 2017 in Review
27 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q4 2017, worth a combined $27.3M — down 30% from $38.7M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CORV and 3 opened new positions — a net loss of 4 holders — while 9 trimmed existing stakes and 6 added.
The largest buyer was Stonepine Capital Management, adding an estimated $528K. The largest seller was AlphaOne Investment Services, cutting an estimated $948K.
- 27 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q4 2017, down from 31 in Q3 2017.
- Funds reported $27.3M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q4 2017, down 30% quarter-over-quarter.
- 3 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q4 2017 and 7 closed out, a net change of -4 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q4 2017 was Stonepine Capital Management, an estimated $528K added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q4 2017 was AlphaOne Investment Services, an estimated $948K sold.
Based on aggregated 13F filings for Q4 2017.